Undetected human papillomavirus DNA and uterine cervical carcinoma

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Strahlentherapie und Onkologie (Print)

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/s00066-015-0909-0PMID 26481139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A study of high-dose-rate intracavitary brachytherapy boost for curative treatment of uterine cervical cancer

  2015cited by this paper
• Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis

  2013cited by this paper
• Persistent human papillomavirus DNA is associated with local recurrence after radiotherapy of uterine cervical cancer

  2011cited by this paper
• Persistence of HPV after radio-chemotherapy in locally advanced cervical cancer.

  2010cited by this paper
• Human papillomavirus testing methods.

  2009cited by this paper
• Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.

  2007cited by this paper
• Chapter 2: The burden of HPV-related cancers.

  2006cited by this paper
• PERSISTENCE OF HUMAN PAPILLOMAVIRUS INFECTION AS A PREDICTOR FOR RECURRENCE IN CARCINOMA OF THE CERVIX AFTER RADIOTHERAPY

  2004influential reference
• Early stage cervical cancers containing human papillomavirus type 18 DNA have more nodal metastasis and deeper stromal invasion.

  2003cited by this paper
• Impact of multiple HPV infection on response to treatment and survival in patients receiving radical radiotherapy for cervical cancer

  2002cited by this paper
• Human papilloma virus (HPV) DNA associated with prognosis of cervical cancer after radiotherapy.

  2002cited by this paper
• Human papillomavirus status in advanced cervical cancer: predictive and prognostic significance for curative radiation treatment

  2001cited by this paper
• The effects of p53 status and human papillomavirus infection on the clinical outcome of patients with Stage IIIB cervical carcinoma treated with radiation therapy alone

  2001cited by this paper
• Improved Amplification of Genital Human Papillomaviruses

  2000cited by this paper
• Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

  1999cited by this paper
• Causes of cervical cancer in the Philippines: a case-control study.

  1998cited by this paper
• Risk factors for cervical cancer in Thailand: a case-control study.

  1998cited by this paper
• Human papillomavirus genotype as a major determinant of the course of cervical cancer.

  1998cited by this paper
• Type of human papillomavirus is related to clinical features of cervical carcinoma

  1996cited by this paper
• Papillomavirus infections--a major cause of human cancers.

  1996cited by this paper
• Correlation of human papillomavirus 16 and 18 with prognostic factors in invasive cervical neoplasias

  1995cited by this paper
• Can a test for E6/E7 transcripts of human papillomavirus type 16 serve as a diagnostic tool for the detection of micrometastasis in cervical cancer?

  1995cited by this paper
• Human papillomavirus infections in women with and without abnormal cervical cytology.

  1987cited by this paper
• Letter: Viruses and gastroenteritis.

  1975cited by this paper

• Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision Oncology

  2025cites this paper
• Current insights on human Papillomavirus-independent cervical cancers: a systematic review

  2025cites this paper
• Predicting the recurrence of usual-type cervical adenocarcinoma using a nomogram based on clinical and pathological factors: a retrospective observational study

  2024cites this paper
• The characteristics of high-risk HPV-negative cervical cancer: a systematic review and meta-analysis

  2024cites this paper
• Prognostic Factors for Cervical Cancer in Asian Populations: A Scoping Review of Research From 2013 to 2023

  2024cites this paper
• Superficial Spread of Nonkeratinizing Squamous Cell Carcinoma of the Cervix to the Endometrium: A Case Report

  2024cites this paper
• High-risk human papillomavirus: prevalence, association with clinical and morphological characteristics of invasive cervical cancer

  2023cites this paper
• Clinicopathological characteristics and survival outcomes in human papillomavirus independent cervical cancer: a propensity score matched analysis

  2022cites this paper
• Prediction of carcinogenic human papillomavirus types in cervical cancer from multiparametric magnetic resonance images with machine learning-based radiomics models

  2022cites this paper
• Plasma Cell-Free DNA in Uterine Cervical Cancer: Therapeutic Monitoring and Prognostic Values after Radical Radiotherapy

  2022cites this paper
• Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy

  2022cites this paper
• The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway

  2022cites this paper
• Mixed and nonvaccine high risk HPV types are associated with higher mortality in Black women with cervical cancer

  2021cites this paper
• High prevalence of mixed and non-vaccine HPV oncogenic types and their association with higher mortality in Black women with cervical cancer

  2021cites this paper
• P16 and HPV Genotype Significance in HPV-Associated Cervical Cancer—A Large Cohort of Two Tertiary Referral Centers

  2021cites this paper
• HPV Status and Individual Characteristics of Human Papillomavirus Infection as Predictors for Clinical Outcome of Locally Advanced Cervical Cancer

  2021cites this paper
• Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas

  2021cites this paper
• Comprehensive Identification of the Human Secretome as Potential Indicators in Treatment Outcome of HPV-Positive and -Negative Cervical Cancer Patients

  2020cites this paper
• Dynamics of Fecal Microbiota with and without Invasive Cervical Cancer and Its Application in Early Diagnosis

  2020cites this paper
• Vaginal Microbiome-Based Bacterial Signatures for Predicting the Severity of Cervical Intraepithelial Neoplasia

  2020cites this paper
• Prognostic significance of negative conversion of high-risk Human Papillomavirus DNA after treatment in Cervical Cancer patients

  2020cites this paper
• Is there any correlation between HPV and early radioresponse before brachytherapy in cervix uteri carcinoma?

  2020cites this paper
• Prevalence, survival outcomes, and clinicopathologic factors associated with negative high risk human papillomavirus in surgical specimens of cervical cancer with pretreatment negative DNA genotype test

  2019cites this paper
• HPV-negative Tumors in a Swedish Cohort of Cervical Cancer

  2019cites this paper
• Low Necroptosis Process Predicts Poor Treatment Outcome of Human Papillomavirus Positive Cervical Cancers by Decreasing Tumor-Associated Macrophages M1 Polarization

  2018cites this paper
• Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.

  2018cites this paper
• Prognostic value of HPV DNA status in cervical cancer before treatment: a systematic review and meta-analysis

  2017cites this paper
• Prevalence and Distribution of High-Risk Human Papillomavirus Genotypes in Invasive Carcinoma of the Uterine Cervix in Uruguay. An update on clinical outcome

  2017cites this paper